Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
StoneX Group $900 million acquisition of R.J. O'Brien & Associates
We are advising StoneX on the transaction
Paychex $4.2 billion senior notes offering
We advised Paychex on its investment-grade notes offering
Lucid $1.1 billion convertible senior notes offering
The 5% convertible senior notes are due 2030
Exchange transaction for NCL exchangeable notes due 2025
Noteholders received new exchangeable notes due 2030, a cash payment and interest
Norwegian Cruise Line Holdings $64 million equity offerings
The shares are listed on the New York Stock Exchange
Owens & Minor $1 billion secured notes offering
The high-yield notes are due 2030
GFL Environmental $900 million secondary offering
The subordinate voting shares are dual-listed on the NYSE and the Toronto Stock Exchange
IRSA $300 million senior notes offering and exchange offer
The new 8% notes are due 2035
MARA Holdings $2 billion at-the-market offering
The shares are listed on the Nasdaq Global Market
Strategy $723 million perpetual strife preferred stock offering
The proceeds will be used to fund in part the acquisition of additional bitcoin